We are pleased to announce the Bio-Rad Quality Control Virtual Conference 2020. This online event brings together Clinical Laboratory Professionals from around the world to discover the latest ...
The firm is projecting a gradual recovery of the academic market in the face of ongoing funding uncertainties and a government shutdown.
HERCULES, Calif.--(BUSINESS WIRE)--Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced a partnership with ...
Zacks Investment Research on MSN
Bio-Rad Laboratories (BIO) Q3 Earnings Miss Estimates
Bio-Rad Laboratories (BIO) came out with quarterly earnings of $2.26 per share, missing the Zacks Consensus Estimate of $2.3 per share. This compares to earnings of $2.01 per share a year ago. These ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback